In IBD reduce symptoms,
maintain remission, and improve
quality of life with...
maintain remission, and improve
quality of life with...
Mesalamine 1.2gm Prolonged Release Tablets
Truly OD for IBD
In Ulcerative Colitis
- First-line treatment for patients with mild-to-moderate UC.
- Has been demonstrated to induce both clinical response and remission, and maintain clinical remission.
- Effect of oral prolonged-release mesalazine (MES) in patients with mild to moderately active ulcerative colitis.
- Induced remission in 42% of patients in ulcerative colitis.
Dosages
- For the induction of remission in patients with active, mild to moderate UC, two or four 1.2 g tablets once daily with food
- For the maintenance of remission in patients with UC, two 1.2 g tablets once daily with food
